WallStreetZenWallStreetZen

NASDAQ: TXG
10x Genomics Inc Stock Ownership - Who owns 10x Genomics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have 10x Genomics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Benjamin J. HindsonPresident and Chief Scientific Officer2025-11-248,283$19.00
$157.36kSell
Adam TaichChief Financial Officer2025-11-2411,888$19.00
$225.85kSell
Serge SaxonovChief Executive Officer2025-11-2413,261$19.00
$251.93kSell
Serge SaxonovChief Executive Officer2025-08-229,348$13.79
$128.88kSell
Benjamin J. HindsonPresident and Chief Scientific Officer2025-08-227,486$13.79
$103.21kSell
Adam TaichChief Financial Officer2025-08-2222,315$13.79
$307.66kSell
Adam TaichChief Financial Officer2025-05-224,044$8.30
$33.56kSell
Benjamin J. HindsonPresident and Chief Scientific Officer2025-05-227,485$8.30
$62.12kSell
Serge SaxonovChief Executive Officer2025-05-229,343$8.30
$77.54kSell
Serge SaxonovChief Executive Officer2025-03-0450,000$1.20
$60.00kBuy

1 of 2

TXG insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TXG insiders and whales buy or sell their stock.

TXG Shareholders

What type of owners hold 10x Genomics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc10.49%13,274,332$213.05MInstitution
Ark Investment Management LLC9.39%11,887,396$190.79MInstitution
Blackrock Inc7.48%9,460,109$151.83MInstitution
Fmr LLC6.68%8,458,001$135.75MInstitution
Paladin Capital Management LLC4.44%5,617,583$90.16MInsider
Millennium Management LLC4.30%5,437,969$87.28MInstitution
Sumitomo Mitsui Trust Group Inc4.25%5,381,219$86.37MInstitution
Amova Asset Management Americas Inc4.25%5,376,883$86.30MInstitution
Bryan E. Roberts3.43%4,336,630$69.60MInsider
Wellington Management Group LLP3.39%4,285,628$68.78MInstitution

1 of 3

TXG vs Health Information Service Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TXG86.48%13.52%Net SellingNet Selling
OMCL94.14%5.86%Net SellingNet Selling
PGNY70.19%29.81%Net BuyingNet Selling
HTFL52.02%35.50%Net BuyingNet Buying
CERT76.55%23.45%Net SellingNet Buying
View Top Health Information Service Stocks

10x Genomics Stock Ownership FAQ

Who owns 10x Genomics?

10x Genomics (NASDAQ: TXG) is owned by 97.29% institutional shareholders, 15.21% 10x Genomics insiders, and 0.00% retail investors. Paladin Capital Management LLC is the largest individual 10x Genomics shareholder, owning 5.62M shares representing 4.44% of the company. Paladin Capital Management LLC's 10x Genomics shares are currently valued at $90.16M.

If you're new to stock investing, here's how to buy 10x Genomics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.